ESC Heart Failure (Feb 2021)

Evidence of evolution towards left midventricular obstruction in severe Anderson–Fabry cardiomyopathy

  • Francesca Graziani,
  • Rosa Lillo,
  • Elena Panaioli,
  • Gionata Spagnoletti,
  • Maurizio Pieroni,
  • Paolo Ferrazzi,
  • Antonia Camporeale,
  • Elena Verrecchia,
  • Ludovico Luca Sicignano,
  • Raffaele Manna,
  • Filippo Crea

DOI
https://doi.org/10.1002/ehf2.13101
Journal volume & issue
Vol. 8, no. 1
pp. 725 – 728

Abstract

Read online

Abstract Aims In Fabry cardiomyopathy, left ventricular outflow tract obstruction mimicking hypertrophic cardiomyopathy is a very rare finding, with few cases reported and successfully treated with cardiac surgery. In our population of patients with Fabry disease and severe left ventricular hypertrophy (LVH) at the time of diagnosis, we observed an evolution towards a midventricular obstructive phenotype. Methods and results We present a case series of three classically affected Fabry male patients with significant diagnostic delay and severe cardiac involvement (maximal wall thickness >20 mm) at first evaluation. All patients developed midventricular obstructive form over time despite prompt initiation and optimal compliance to enzyme replacement therapy. The extension and distribution of the LVH, involving the papillary muscles, was the main mechanism of obstruction, unlike the asymmetric septal basal hypertrophy and the mitral valve abnormalities commonly seen as substrate of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Conclusions Fabry cardiomyopathy can evolve over time towards a midventricular obstructive form due to massive LVH in classically affected men with significant diagnostic delay and severe LVH before enzyme replacement therapy initiation. This newly described cardiac phenotype could represent an adverse outcome of the disease.

Keywords